Action Pharma makes appointments
This article was originally published in Scrip
Action Pharma, a privately owned Danish biotech company, has appointed Ingelise Saunders as its new chief executive officer. The company's former CEO, Søren Nielsen, becomes chief operating officer and continues as part of Action's executive management group. Ms Saunders was president and CEO of ACE BioSciences (Denmark) for five years. Before that, she served as CEO of Celltech Pharmaceuticals (UK) for three years and spent 16 years with Novo Nordisk in senior executive management positions, both in Denmark and the UK.